REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet

BELFAST HEALTH AND SOCIAL CARE TRUSTcontractFind a TenderRef ocds-h6vhtk-06b676Procurement Act 2023active
View buyer

Estimated value

Awarded value

£1.0m

Awarded 16 Jun 2026

Suppliers

1

Lots

1

1 awarded

Published

17 Jun 2026

Other contracts from BELFAST HEALTH AND SOCIAL CARE TRUST· 10

Most recent notices published by the same contracting authority.

View buyer profile →
TitleTypeValuePublished
Laryngoscope Handles and Bladescontract£1.6m15 Jun 2026
Vascular Grafts and Associated Surgical Consumablescontract£446k15 Jun 2026
Patient Positioning Pads for Laparoscopic Surgerycontract15 Jun 2026
Orthopaedics – Hip and Knee Replacement Productscontract£45.0m15 Jun 2026
Promotional Products and Standscontract£4.1m09 Apr 2026
Maintenance of LithoClast Triloglycontract£199k27 Mar 2026
BHSCT Maintenance of Agilent Laboratory Equipmentcontract£317k27 Mar 2026
Maintenance of Generator Sets including Alternators, Control Systems, Local and Remote ACB Switching Controlscontract£12.9m05 Mar 2026
Total Cellular Pathology Solution - 2805386contract04 Mar 2026
Urine, Cerebrospinal Fluid (CSF) and body fluids microscopy analyser(s), consumables, reagents and Quality Controlcontract£1.4m04 Mar 2026

Other contracts awarded to NOVARTIS PHARMACEUTICALS UK LIMITED· 10

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →
TitleTypeValuePublished
REVOLADE (ELTROMBOPAG) TABLETS, 28 tabletcontract17 Jun 2026
TRAMETINIB 2MG TABLETS, 30 tablet, pack, PACK OF 1contract05 May 2026
NHS National Branded Interim - 1 June 2026contract16 Apr 2026
Generic, Branded Generic & Proprietary Medicinal Products - Group 17contract12 Jan 2026
NHS National Framework Agreement for Omalizumabcontract30 Dec 2025
NHS National Framework for Generics Housekeepingcontract22 Dec 2025
Contract for Netspot (Gallium Ga 68 Dotatate)contract08 Dec 2025
NHS National Framework Agreement for Omalizumabcontract28 Nov 2025
NHS National Framework for Generics Housekeepingcontract11 Nov 2025
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injectioncontract10 Nov 2025